The arcuate nucleus of the hypothalamus is essential for metabolic homeostasis and responds to leptin by producing several neuropeptides including proopiomelanocortin (POMC). We previously reported that high-dose erythropoietin (Epo) treatment in mice while increasing hematocrit reduced body weight, fat mass, and food intake and increased energy expenditure. Moreover, we showed that mice with Epo receptor (EpoR) restricted to erythroid cells (DEpoR E ) became obese and exhibited decreased energy expenditure. Epo/EpoR signaling was found to promote hypothalamus POMC expression independently from leptin. Herein we used WT and DEpoR E mice and hypothalamus-derived neural culture system to study the signaling pathways activated by Epo in POMC neurons. We show that Epo stimulation activated STAT3 signaling and upregulated POMC expression in WT neural cultures. DEpoR E mice hypothalamus showed reduced POMC levels and lower STAT3 phosphorylation, with and without leptin treatment, compared to in vivo and ex vivo WT controls. Collectively, these data show that Epo regulates hypothalamus POMC expression via STAT3 activation, and provide a previously unrecognized link between Epo and leptin response.
Introduction
The hematopoietic cytokine erythropoietin (Epo), the primary regulator of erythrocyte production, is mainly produced in the kidneys in a hypoxia-dependent manner. Epo receptor (EpoR) expression is highest in erythroid progenitors, and its deletion in mice (EpoR K/K ) is embryonic lethal due to severe anemia (Wu et al. 1995) . In addition, EpoR signaling in non-hematopoietic cells has pleiotropic effects beyond erythropoiesis (Noguchi et al. 2008 , Alnaeeli et al. 2012 . In the brain, Epo has been associated with neurogenesis, neuroprotection, neural progenitor cell (NPC) migration, and memory retrieval (Shingo et al. 2001 , Tsai et al. 2006 , Wang et al. 2006 , Chen et al. 2007 , Miskowiak et al. 2007 , Mengozzi et al. 2012 . Epo treatment in mice increases hematocrit and can also increase energy expenditure, reduce blood glucose levels, and reduce appetite and body fat mass (Hojman et al. 2009 , Katz et al. 2010 , Foskett et al. 2011 . Expression of an erythroid tissuespecific EpoR transgene rescued the embryonic lethal phenotype in EpoR K/K mice (Suzuki et al. 2002) . This mouse model has EpoR expression restricted to erythroid tissue (DEpoR E ) (Suzuki et al. 2002) . Previously, we reported that DEpoR E mice exhibit increased body weight from the first postnatal week, show decreased energy expenditure, and develop metabolic syndromes with age via effects on white adipose tissue and hypothalamus .
The hypothalamus is a major central neuroendocrine regulation center involved in the control of energy homeostasis via orexigenic agouti-related peptide (AgRP)/ neuropeptideY (NPY)-producing neurons and anorexigenic proopiomelanocortin (POMC)-producing neurons (Bouyer & Simerly 2013) . Ablation of POMC neurons and loss of POMC-derived transmitters lead to obesity (Yaswen et al. 1999) , further underscoring the importance of POMC neurons in regulation of energy homeostasis. Considering our reported findings that show high EpoR expression in hypothalamus, regulation of appetite and energy expenditure by exogenous Epo treatment in mice, and POMC induction in response to Epo treatment (Foskett et al. 2011 ), here we examine the regulation of hypothalamus POMC neuron function/response to Epo/EpoR signaling.
Leptin, a hormone secreted by adipose tissue into the circulation, binds its long-form receptor (LepRb) in the arcuate nucleus of the hypothalamus and activates signal transducer and activator of transcription 3 (STAT3), which positively regulates POMC expression (Bates et al. 2003) . The largest population of LepRb-expressing neurons is in the hypothalamus (Zuure et al. 2013) . Mice lacking leptin, LepRb, or STAT3 genes become obese with a concomitant decrease in POMC expression (Gao et al. 2004 , Diano et al. 2011 , Harlan et al. 2011 . Conversely, leptin treatment in mice reduced food intake and increased oxygen consumption (Coppari et al. 2005) . Interestingly, Epo and leptin are both members of the hematopoietic cytokine superfamily and have similar protein structure (Ouyang & He 2003 , Fruhbeck 2006 , receptor structure (Constantinescu et al. 2001 , Mancour et al. 2012 , and signaling mechanism (Banks et al. 2000 , Zhang et al. 2014 , and stimulate anorexic response after administration (Balthasar et al. 2004 . Therefore, here we investigate potential links between Epo and leptin action, regulation of hypothalamus POMC neuron function/response to Epo/EpoR signaling, and potential cross talk between Epo and leptin signaling in POMC neurons.
Materials and methods

Animal studies
DEpoR E mice were generated using the TgEpoR transgene consisting of EpoR cDNA driven by the GATA-1 locus erythroid regulatory domain (Suzuki et al. 2002) bred onto an EpoR null (EpoR K/K ) background. This rescues the EpoR K/K phenotype from severe anemia and death in utero (Suzuki et al. 2002) . These DEpoR E mice can survive through adulthood and their hematocrits are normal. The DEpoR E mice are on of C57BL/6 background and age-matched C57BL/6 WT mice were used as controls. For Epo treatment (3000 U/kg body weight; Epoetin alpha, Amgen, Thousand Oaks, CA, USA), the mice received s.c. injections three times at 0930 h per week. For leptin treatment (5 mg/kg body weight; Peprotech, Rocky Hill, NJ, USA), mice received i.p. injection twice daily (0930 h and 1730 h) for three consecutive days. Mice were housed in individual cages for body weight and food intake studies, kept on 12 h light/darkness cycle, and fed normal chow diet. Studies were conducted following National Institutes of Health guidelines under institution-approved animal protocol.
NPC cultures
Embryos at 15.5 days (E15.5) were harvested from pregnant mice. The developing hypothalamus and cortex were dissected and transferred separately to serum-free media containing DMEM (with L-glutamine)/F12 (1:1) (Invitrogen) supplemented with B27 (Invitrogen), EGF (PeproTech, 20ng/ml), FGF-2 (PeproTech, 20 ng/ml), and 0.5 units/ml Pen-Strep (Invitrogen). Hypothalamus and cortex tissues were mechanically dissociated into single-cell suspension with a pipette. Cultures were also established from hypothalamus of newborn WT and DEpoR E pups. Cell viability was assessed using trypan blue exclusion. Dissociated cells were cultured as an adherent monolayer and seeded on tissue culture plates pre-coated with 15 mg/ml poly-L-ornithine (PLO) (Sigma) and 1 mg/ml laminin (Sigma) with a seeding density of 1!10 5 cells/cm 2 . After 7 days, cells reached around 90% confluency and were passaged at 1:4 to new plates and designated as passage 1. Expansion cultures were passaged every 5 days regularly from first passage onward at 1:4 ratio and recorded as passage 2 through passage 10. 
Quantitative RT-PCR
Immunofluorescence analysis
After overnight fasting, mice were treated either with leptin, Epo, or saline at 0930 h. After 90 min, animals were anesthetized with isoflurane and perfused with ice-cold PBS via the heart and then fixed with 100 ml of 4% paraformaldehyde (PFA) solution (Sigma). Brain was removed, post-fixed overnight in 4% PFA, followed by overnight cryoprotection in 30% sucrose, and cut in 10-mm coronal sections, collected in five series. 
Results
Primary hypothalamus NPC cultures express POMC and EpoR
We previously reported that EpoR protein in mouse hypothalamus localizes to POMC-expressing neurons, and Epo directly regulates POMC expression in these neurons . To study Epo/EpoR-mediated regulation of POMC in mouse hypothalamus, we established NPC cultures from E15.5 mouse hypothalamus. For comparison, primary NPCs derived from E15.5 hippocampus and cortex were used because these brain regions also express EpoR (Yu et al. 2002 , Chen et al. 2007 . POMC expression in the respective cultures, determined by quantitative RT-PCR, revealed that POMC mRNA was mainly expressed in hypothalamus-derived NPC cultures and ten times higher than levels detected in cultures derived from cortex or hippocampus (Fig. 1A) . In contrast, EpoR mRNA expression was readily detected in NPC cultures from each of these three regions with expression highest in the hippocampus. The levels in the hypothalamus were one-half to one-third the levels in the hippocampus or cortex (Fig. 1B) .
NPC cultures as an adherent monolayer are prone to density-dependent differentiation. Adherent NPC cultures were passaged when confluence was O90% to promote density-dependent differentiation. With increasing passage, nestin mRNA expression decreased by more than an order of magnitude (Fig. 1C) Densitometry data is representative of three independent experiments. Statistical significance is indicated by *P!0.05, **P!0.01, and ***P!0.001 (one-way ANOVA followed by Bonferroni correction). (H) Double fluorescent immunostaining for POMC (green) and EpoR (red) on hypothalamus NPC cultures at passage 3 and stained with DAPI staining (blue) for nuclei and merged for triple stained image. Scale bar represents 100 mm.
( Fig. 1D) , indicating a shift from NPCs to immature neurons concomitant with an increase in POMC and EpoR mRNA expression ( Fig. 1E and F) . POMC protein production examined by western blotting increased between passage 1 and passage 3, was maximal between passages 3 and 5, and then decreased by passage 8 (Fig. 1G ). These data suggest that the increase in POMC expression and protein production in these cultures correlates with a shift in nestin-expressing NPCs toward b-tubulin-and POMC-expressing immature neurons with a maximal shift occurring between passages 3 and 5. At passage 10, EpoR mRNA continued to be expressed, but b-tubulin and POMC mRNA levels declined ( Fig. 1D and E). Immunostaining of passage 3 cells also showed colocalization of POMC and EpoR protein expression and the presence of cells that did not stain for either, suggesting EpoR expression is specific for POMC neurons in this population of cells (Fig. 1H ). These POMC-and EpoR-expressing cells comprised w50% of total cell population in culture at this stage. Moreover, there were no cells that expressed EpoR only, and not POMC.
Immunostaining of passage 1 cells with anti-POMC and anti-EpoR antibodies served as negative controls and confirmed the specificity of these antibodies. The apparent patterns of cytoplasmic anti-EpoR staining in POMC neurons may relate to the processing and trafficking of EpoR and the reported observations that only a minor fraction of the Golgi-processed receptor is on the cell surface and a few high affinity Epo surface binding receptors in neuronal cells are sufficient for Epo-activated cell signaling (Hilton et al. 1995 , Um et al. 2007 . In all subsequent experiments, cells from passages 3 to 5 which showed optimum POMC and EpoR expression were used. In cortex-derived NPC cultures, the low level of POMC expression did not increase with time in passage indicating that cortex-derived NPCs did not exhibit the ability to self-differentiate into POMC-expressing neurons (data not shown).
Epo increases POMC expression in hypothalamus NPC cultures via JAK2/STAT3 pathway
Epo treatment of hypothalamus NPC cultures increased POMC mRNA expression in a dose-dependent manner as determined by quantitative RT-PCR ( Fig. 2A) . Similar increase in POMC protein expression was also observed as determined by western blotting (Fig. 2B ). In addition to regulating POMC, Epo treatment increased JAK2-and STAT3-phosphorylation in NPC cultures (Fig. 2C) . Pretreatment with STAT3 inhibitor WP1066 (3 mM) for 30 min was sufficient to abrogate Epo induction of POMC (Fig. 2D) . While b-tubulin expression did not change with Epo treatment, there was a modest decrease (10% or less) in b-tubulin with WP1066 treatment with and without Epo (Fig. 2F) . These results suggest that STAT3 phosphorylation is required for Epo induction of POMC and that inhibition of STAT3 phosphorylation by WP1066 decreases POMC expression by reducing the amount of POMC expression with minimal change in b-tubulin and the proportion of cells with the potential to express POMC. Epo treatment of hypothalamus NPC cultures at 10 and 20 U/ml also resulted in a small but significant increase in cell number in a dose-dependent manner at both 32 h and 48 h of treatment (Fig. 2F) .
Loss of EpoR signaling in hypothalamus NPC cultures affects their leptin response
We previously reported that leptin is not required for the effects of exogenous Epo treatment on body weight and fat mass loss . However, Epo signaling in NPC is mediated via STAT3 pathway (Fig. 2) , which is also activated in the arcuate nucleus after leptin treatment. Whether Epo/EpoR signaling affects leptin response in hypothalamus was unknown. To investigate this question, hypothalamus-derived NPC cultures were generated from neonate WT and DEpoR E mice. With leptin and Epo treatment, WT cultures showed an increase in STAT3 phosphorylation (Fig. 3A) . In contrast, NPC cultures from DEpoR E mice did not show the increase in STAT3 phosphorylations expected with Epo treatment (Fig. 3A) . Interestingly, DEpoR E hypothalamus cultures also did not exhibit the expected increase in STAT3 phosphorylation with leptin treatment (Fig. 3A) . Of note, baseline levels of STAT3 phosphorylation were lower in DEpoR E hypothalamus NPC cultures compared to those from WT hypothalamus (comparing saline treatment lanes, Fig. 3A) . Moreover, Epo and leptin combination treatments were not more effective than Epo or leptin treatment alone in inducing STAT3 phosphorylation (Fig. 3A) . Consistent with STAT3 activation, 24 h treatment with either leptin or Epo increased POMC mRNA expression in WT hypothalamus cultures by two-to 2.5-fold, with combination treatment no better than individual treatment conditions (Fig. 3B) . In DEpoR E hypothalamus cultures, baseline POMC mRNA expression appeared to be fourfold lower than WT cultures, but was induced approximately twofold by leptin or the combination of leptin plus Epo treatment, but not by Epo alone (Fig. 3B) . Note that even with leptin treatment, POMC expression in DEpoR E cultures was only half the level of control-treated WT cultures (Fig. 3B) , and no significant induction in STAT3 phosphorylation was detected (Fig. 3A) . Conversely, NPY and AgRP mRNA expression did not show any difference between WT and DEpoRE hypothalamus NPC cultures, and was reduced similarly by leptin treatment only ( Fig. 3C and D) . Combination treatment or Epo alone did not affect either NPY or AgRP mRNA expression ( Fig. 3C and D) . These data support the previous finding that EpoR expression is specific for POMC neurons ) and lack of EpoR neither affect NPY and AgRP expression nor its response after leptin treatment. These observations collectively point to an important and previously unrecognized role for EpoR signaling to contribute to leptin response in hypothalamus NPC ex vivo. Interestingly, LepRb mRNA levels showed a small but significant reduction in DEpoR E cultures compared to the WT (Fig. 3E ), but cell proliferation during the NPC culture is not affected by loss of EpoR (Fig. 3F) .
Absence of hypothalamus EpoR signaling reduces in vivo STAT3 phosphorylation and POMC production, blunts leptin-induced STAT3 activation but not the leptin-induced relative increase of POMC Ex vivo hypothalamus NPC cultures provided evidence for Epo-stimulated STAT3-activation (Figs 2 and 3 ). Loss of endogenous Epo activity in DEpoR E hypothalamus should also reduce STAT3 phosphorylation in vivo. DEpoR E mice show age-dependent obesity, and at 8 months are 30% or greater in body mass vs WT due to increased fat mass with a corresponding increase in circulating leptin levels . To avoid this apparent obesity related increase in leptin level and the expected change in STAT3 phosphorylation related to increased leptin signaling, we examined hypothalamus STAT3 phosphorylation in young mice prior to development of fat tissue. At postnatal day 2-3, STAT3 phosphorylation in the hypothalamus of DEpoR E mice was reduced by threefold compared with WT mice while levels of total STAT3 were comparable (Fig. 4A) . The difference in STAT3 phosphorylation was also evident in DEpoR E mice at postnatal day 4-5 ( Fig. 4B) . Regulation of body weight involves a balance between energy intake and energy expenditure. Leptin has the ability to decrease food intake, increase energy expenditure and promote body weight loss. We investigated whether the changed energy balance of DEpoR E mice involved alterations in leptin-mediated signaling in the hypothalamus (Fig. 4C and F) . Three-week old mice were used to eliminate possible leptin resistance associated with older, obese DEpoR E mice, and also to ensure complete development of neurons of the arcuate nucleus. DEpoR E hypothalamus showed a lower level of STAT3 phosphorylation compared to WT hypothalamus (Fig. 4C) . However, the difference is reduced compared with mice at postnatal days 2-3 (Fig. 4A ) and days 4-5 old (Fig. 4B ). This suggests that DEpoR E mice by 3 weeks develop a compensatory mechanism that restores STAT3 phosphorylation closer to normal WT levels. In contrast to ex vivo DEpoR E hypothalamus cultures that show no leptin-induced STAT3 phosphorylation (Fig. 3A) , DEpoR E mice exhibited a blunted in vivo leptin-induced STAT3 phosphorylation in hypothalamus compared with WT mice (Fig. 4C) . This suggests that, in vivo, other mechanisms attempt to compensate for the apparent loss of direct leptin induction of STAT3 phosphorylation in hypothalamus NPC derived cells.
In vivo, baseline POMC protein levels were lower in DEpoR E mice, analogous to the reduced POMC mRNA in DEpoR E hypothalamus cultures (Fig. 3B) , and leptin could induce POMC expression only up to baseline WT levels (Fig. 4D) . These data suggest that in vivo leptin response in DEpoR E hypothalamus is blunted with respect to STAT3 phosphorylation, and the reduction in baseline STAT3 EpoR signaling is required for optimum leptin response in NPC cultures. (A) Western blotting and quantitative densitometry analysis were used to determine levels of phosphorylated-STAT3, total-STAT3, and b-Actin protein levels (A), in WT and DEpoR E NPC cultures after control saline treatment, Epo treatment, EpoCleptin treatment, and leptin treatment. Epo and leptin was used at 20 U/ml and 1000 U/ml respectively and densitometry analysis is representative of three independent experiments (B, C and D) POMC (B), NPY (C), and AgRP (D) mRNA expression in WT and DEpoR E NPC cultures were determined after Epo, EpoCleptin, and leptin treatments, relative to control saline-treated WT cells. (E) LepRb mRNA expression in WT and DEpoR E NPC cultures. Gene expressions were adjusted to b-Actin mRNA levels and RT-PCR reactions were run in triplicate. (F) Fold change in numbers of NPC from WT and DEpoR E E15.5 embryos. P0 represents cell proliferation from day 1 to day 7 of culture, and P1-P5 represents passages 1-5 after every 5 days. Fold change is representative of three independent experiments. Statistical significance is indicated by *P!0.05, **P!0.01 and ***P!0.001 (one-way ANOVA followed by Bonferroni correction). activation results in a lower level of POMC in DEpoR E mice, compared with WT mice without and with leptin treatment. Leptin induction of POMC in both WT and DEpoR E mice was also reflected in a small but significant decrease in body weight after leptin treatment in WT mice (6%) and in an apparent smaller decrease in DEpoR E mice (2.5%) (Fig. 4E) . Food intake for 3 days was significantly lower in leptin-treated WT mice, and also showed a DEpoR E mice show blunted STAT3 activation but equivalent POMC induction in the hypothalamus after leptin treatment compared to WT mice. (A and B) Western blotting and quantitative densitometry analysis (from three pups each of WT and DEpoR E ) were used to compare phosphorylated-STAT3 (p-STAT3), total-STAT3 (t-STAT3), and GAPDH protein levels in WT and DEpoR E pups at postnatal day 2-3 (A) and postnatal day 4-5 (B). (C and D) Western blotting and quantitative densitometry analysis demonstrating phosphorylated-STAT3 (p-STAT3) and total-STAT3 (t-STAT3) (C), POMC and GAPDH (D) in a 3-week-old female WTand DEpoR E mice 45 min after treated with leptin (5 mg/kg body weight) or saline (nZ3 for each treatment group). (E and F) Body weight (E), and food intake (F) were determined in WT and DEpoR E mice after saline-or leptin-treatment twice daily for 3 days (nZ4 for each treatment group). Statistical significance is indicated by *P!0.05, and **P!0.01 (one-way ANOVA followed by Bonferroni correction).
reduced trend in DEpoR E mice (Fig. 4F) . In summary, these data suggest that loss of EpoR in young mice reduces baseline hypothalamus STAT3 activation and lowers POMC expression in the hypothalamus. Moreover, leptin sensitivity with respect to body weight loss and reduced food intake are still evident in DEpoR E mice.
Finally, immunohistochemical staining of brain sections displaying the arcuate nucleus region of the hypothalamus also showed lower staining for a-MSH, a cleavage product of POMC, in DEpoR E mice compared to WT mice (Fig. 5A and B) . Both Epo and leptin treatment of WT mice induced a-MSH expression ( Fig. 5C and E) . Induction of a-MSH, a POMC product, in the arcuate nucleus region of the mouse brain after either saline, Epo, or leptin treatment. Representative fluorescence photomicrographs for a-MSH immunoreactivity in brain sections prepared from the mouse mediobasal hypothalamus consisting of the arcuate nucleus region are shown. Three-week old female WT (A, C and E) or DEpoRE (B, D and F) mice were treated with either saline (A and B), Epo (3000 U/kg body weight) (C and D), or Leptin (5 mg/kg body weight) (E and F). Scale bar represents 100 mm. 3V, third ventricle; ARC, arcuate nucleus; ME, median eminence.
As expected, the DEpoR E mice brain sections showed higher immunoreactivity to a-MSH only after leptin treatment and not Epo treatment ( Fig. 5D and F) .
Discussion
EpoR is expressed in the POMC neurons of the hypothalamus, a master regulatory site of appetite and energy expenditure, and the increased POMC expression in Epotreated WT mice suggested that Epo could directly stimulate these POMC neurons , although the detailed mechanism of POMC neuron response to Epo was uncertain. We previously showed that Epo treatment in WT mice decreases body weight and fat mass by reducing food intake and increasing energy expenditure (Foskett et al. 2011 . While EpoR is expressed in several brain regions including hypothalamus, hippocampus and cortex, NPC cultures from the hypothalamus show unique induction of POMC expression with Epo treatment. Using hypothalamusderived NPC cultures, we studied the signaling pathways activated by Epo in POMC neurons and investigated the crosstalk between LepRb and EpoR signaling. Epo and leptin are both members of the class-I cytokine superfamily (Ouyang & He 2003 , Fruhbeck 2006 and act through the JAK/STAT signaling pathway (Constantinescu et al. 2001 , Mancour et al. 2012 . Leptin stimulation of POMC expression in the hypothalamus is mediated via STAT3 activation (Bates et al. 2003) and we found that Epo-stimulated increase of POMC is also dependent on STAT3 activation. The requirement for EpoR for normal hypothalamus response is further confirmed by analysis of hypothalamus from DEpoR E mice with EpoR expression restricted to erythroid tissue. Neonatal DEpoR E mice show reduced STAT3 phosphorylation and lower level of POMC expression in the hypothalamus compared with WT mice. In addition, corresponding hypothalamus NPC cultures from DEpoR E mice lack activation of STAT3 or induction of POMC with Epo treatment. Evidence that loss of EpoR may blunt the leptin response is further suggested by ex vivo findings from DEpoR E hypothalamus cultures that also exhibit loss of leptin-induced increase in STAT3 phosphorylation. These data provide evidence that endogenous Epo signaling in WT hypothalamus contributes to STAT3 phosphorylation while loss of Epo signaling reduces endogenous baseline level of STAT3 activation and POMC production. The reduction in endogenous STAT3 activity in DEpoR E mice is consistent with the severe obese phenotype observed in mice with neural-specific disruption of STAT3 that underscore its importance in the CNS in regulating energy homeostasis (Gao et al. 2004) . Interestingly, with leptin treatment in the DEpoR E mice, induction of STAT3 phosphorylation in the hypothalamus is reduced to half that in treated WT mice. While the low level of POMC expression in DEpoR E hypothalamus is increased with leptin treatment and fold induction of POMC in DEpoR E and WT hypothalamus are similar, the level of POMC remains 50% or less than treated WT hypothalamus. The lack of leptin induced STAT3 activation observed in DEpoR E hypothalamus cultures suggests that other Epo-independent signaling pathways compensate in part to provide leptin induced POMC expression in DEpoR E hypothalamus. Epo influence on leptin-responsive weight loss is also suggested by the lower percentage weight decrease in DEpoR E mice.
The finding that leptin requires functional EpoR for normal levels of STAT3 activation and POMC induction in hypothalamus provides an explanation for the low POMC levels in hypothalamus of DEpoR E mice despite elevated circulating leptin levels and for the resultant altered energy homeostasis , and suggests disruption of critical leptin regulation of energy efficiency in the hypothalamus. However, a combination of Epo/ leptin treatment did not induce higher POMC expression, which raises the possibility that Epo may prime POMC neurons in the hypothalamus for subsequent leptin action, and the kinetics of treatment is critical to see a combined Epo/leptin effect on POMC expression. Although lack of EpoR does not affect NPC proliferation in culture, LepRb expression is modestly reduced in DEpoR E NPC cultures. This raises the possibility that EpoR signaling is required for the complete maturation of POMC neurons without affecting its numbers.
These data suggest that direct response by the hypothalamus to Epo treatment contributes, in part, to regulation of body weight and fat mass via STAT3 activation and POMC induction. The DEpoR E mice provide further evidence that increased metabolic load of Epo-stimulated erythropoiesis cannot explain the body weight reduction after Epo treatment in WT mice. Specifically, DEpoR E mice treated with Epo exhibit the expected increase in hematocrit, but without the significant reduction in body mass observed in WT mice . Finally, transgene-driven expressions of EpoR in DEpoR E mice hematopoietic cells and spleen are comparable to endogenous EpoR levels and also DEpoR E mice do not show any difference in hematocrit levels (Suzuki et al. 2002 ).
Leptin receptor is distributed in the arcuate nucleus and other regions of the hypothalamus and in extrahypothalamic autonomic control sites as well as cortex and hippocampus (Caron et al. 2010) , indicating that leptin response associated with energy balance involves multiple regions of the brain. EpoR is also expressed in various sites in the brain, such as cortex and hippocampus that are also linked to food intake (Morton et al. 2006 , Volkow et al. 2011 , raising the possibility that Epo activity in the brain beyond POMC neurons may modulate metabolic activity. Although AgRP/NPY neurons in the arcuate nucleus of the hypothalamus also contribute to leptin regulation of POMC, EpoR expression was not detected in AgRP/NPY neurons . Moreover, we did not see any difference in AgRP and NPY expression between WT and DEpoRE hypothalamus NPC cultures, and NPY expression was reduced after leptin treatment only. This also suggests that the effect we see in DEpoR E mice is specifically due to Epo-mediated regulation of POMC neurons and not due to secondary effects on AgRP and NPY neurons.
Similar to acute leptin administration (Hill et al. 2008) , exogenous Epo treatment in WT mice also results in a reduction in food intake and body weight, and an increase in physical activity with activation of POMC neurons . The uncoupling of food intake and energy expenditure has been observed in POMC neurons, and selective deletion of leptin receptor in POMC neurons fails to affect food intake (Balthasar et al. 2004) . It has been argued that neural control over feeding behavior has several layers of redundancy (Schwartz et al. 2003) . It should be noted that although the knockout of anorexigenic neuropeptide-expressing POMC gene causes increased food intake (Yaswen et al. 1999) , the knockout of orexigenic NPY gene does not affect daily food intake (Erickson et al. 1996) . In this regard, we observed that the DEpoR E mice that show a 50% reduction in POMC expression in the hypothalamus develop obesity, with reduced physical activity, but no detectable increase in food intake .
Endogenous Epo is present in brain and cerebral spinal fluid (Chavez et al. 2006) , in addition to the adult kidney, Epo can be produced in an oxygen-dependent manner by astrocytes and neurons (Chavez et al. 2006) and provide a local source for Epo production to stimulate the EpoRexpressing neural cells in the hypothalamus. Interestingly, hypothalamic astrocytes have also been suggested to influence metabolic status and obesity (Fuente-Martin et al. 2012) . High fat diet feeding in mice results in inflammatory response and increase in pro-inflammatory markers in astrocytes, together with a decrease in POMC neurons in the arcuate nucleus (Thaler et al. 2012) .
Overall, in this study we identified a previously unknown mechanism of EpoR-dependent regulation of POMC expression via STAT3 activation and LepRb signaling in the hypothalamus. We further explored the molecular links underlying the contribution of loss of EpoR in non-hematopoietic tissue to the obese phenotype in DEpoR E mice. Our study also identified the importance of endogenous Epo signaling in regulation of energy homeostasis.
